Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
about
Decreased Expression of Sphingosine-1-Phosphate Receptor 1 in the Blood Leukocyte of Rheumatoid Arthritis PatientsNatural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host MicrobiomeThe small molecule NSM00191 specifically represses the TNF-α/NF-кB axis in foot and ankle rheumatoid arthritisAn enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome‑protamine-DNA-siRNA complex with cell permeable peptides
P2860
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@en
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@nl
type
label
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@en
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@nl
prefLabel
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@en
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@nl
P2093
P2860
P1433
P1476
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
@en
P2093
P2860
P2888
P356
10.1038/S41413-018-0016-9
P577
2018-04-27T00:00:00Z
P6179
1103640955